Standout Papers
- Association of Obesity With Survival Outcomes in Patients With Cancer (2021)
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer (2014)
- Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer (2016)
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study (2015)
Immediate Impact
1 by Nobel laureates 6 from Science/Nature 65 standout
Citing Papers
Pancreatic cancer
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Gianluca Tomasello being referenced
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
2023
RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gianluca Tomasello | 3570 | 1672 | 918 | 126 | 4.8k | |
| Bruce J. Giantonio | 3309 | 1541 | 721 | 123 | 4.9k | |
| Stephen K. Williamson | 3917 | 1885 | 1274 | 147 | 5.9k | |
| Jae Kyung Roh | 4123 | 1774 | 1144 | 151 | 5.7k | |
| Vincenzo Catalano | 3062 | 1595 | 1142 | 124 | 5.0k | |
| Gennaro Galizia | 2754 | 1879 | 1292 | 139 | 5.1k | |
| Jeremy Shapiro | 3257 | 1448 | 724 | 141 | 4.5k | |
| Arnaud Roth | 3334 | 1798 | 1251 | 115 | 5.0k | |
| John Souglakos | 3145 | 1941 | 887 | 166 | 5.1k | |
| Benjamin Tan | 2807 | 1856 | 1582 | 160 | 4.9k | |
| Michelle R. Mahoney | 3301 | 1667 | 1131 | 71 | 4.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...